3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Prostatic Neoplasms
8
Neoplasms
4
Colorectal Neoplasms
4
Breast Neoplasms
3
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Precancerous Conditions
2
Male Urogenital Diseases
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Vascular Diseases
1
Thrombocytopenia
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Non-melanoma Skin Cancer
1
Neurotoxicity Syndromes
1
Myocardial Ischemia
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphedema
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
Diclofenac
2
whole grape extract
1
Vitamin E
1
Tomography, Optical Coherence
1
Selenium
1
Negative-Pressure Wound Therapy
1
Eflornithine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Non-melanoma Skin Cancer
×
Vitamin E
×
Clear all
NCT00392561
2023-04-26
BEST
University of Chicago
Phase NA
Completed
7,000 enrolled